Increased expression of caspase 2 in experimental and human temporal lobe epilepsy

NeuroMolecular Medicine

Volumn 9, Issue 2, 2007, Pages 129-144

  Narkilahti, Susanna ^a,b   Jutila, Leena ^c   Alafuzoff, Irina ^c   Karkola, Kari ^c   Paljärvi, Leo ^c,d   Immonen, Arto ^c   Vapalahti, Matti ^c   Mervaala, Esa ^c   Kälviäinen, Reetta ^c   Pitkänen, Asla ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Caspase; Epileptogenesis; Kainic acid; Neurodegeneration; Programmed cell death; Seizure

Indexed keywords

CASPASE 2;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; CELL DEATH; CELL LABELING; COURSE EVALUATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; EPILEPTIC STATE; EPILEPTOGENESIS; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; TEMPORAL LOBE EPILEPSY; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; APOPTOSIS; CASPASE 2; EPILEPSY, TEMPORAL LOBE; EXCITATORY AMINO ACID AGONISTS; FEMALE; HIPPOCAMPUS; HUMANS; KAINIC ACID; MALE; MIDDLE AGED; MODELS, ANIMAL; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS;

RATTUS;

EID: 34447580131     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02685887     Document Type: Article

References (65)

1. Alnemri E. S. (1997) Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J. Cell Biochem. 64, 33-42.
2. Annunziato L., Amoroso S., Pannaccione A., et al. (2003) Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol. Lett. 139, 125-133.
3. Ben-Ari Y. (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14, 375-403.
4. Bengzon J., Mohapel P., Ekdahl C., and Lindvall O. (2002) Neuronal apoptosis after brief and prolonged seizures, in Do seizures damage the brain?, Sutula T. and Pitkänen A. eds., Elsevier, vol. 135, pp. 111-119.
5. Bergeron L., Perez G. I., Macdonald G., et al. (1998) Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12, 1304-1314.
6. Chang H. Y. and Yang X. (2000) Proteases for cell suicide: functions and regulation of caspases. Microbiol. Mol. Biol. Rev. 64, 821-846.
7. Cheung H. H., Kelly L. N., Liston P., and Korneluk R. G. (2006) Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp. Cell Res. 312, 2347-2357.
8. Clark R. S., Kochanek P. M., Chen M., et al. (1999) Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J. 13, 813-821.
9. Cohen G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16.
10. Crespel A., Coubes P., Rousset M. C., et al. (2002) Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res. 952, 159-169.
11. Desjardins P. and Ledoux S. (1998) Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex. Neurosci. Lett. 244, 69-72.
12. Dorr J., Bechmann I., Waiczies S., et al. (2002) Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J. Neurosci. 22, RC209.
13. Duan H. and Dixit V. M. (1997) RAIDD is a new 'death' adaptor molecule. Nature 385, 86-89.
14. Ferrer I., Lopez E., Blanco R., Rivera R., Krupinski J., and Marti E. (2000) Differential c-Fos and caspase expression following kainic acid excitotoxicity. Acta. Neuropathol. (Berl.) 99, 245-256.
15. Fountain N. B. and Lothman E. W. (1995) Pathophysiology of status epilepticus. J. Clin. Neurophysiol. 12, 326-342.
16. Fujikawa D. G. (2005) Prolonged seizures and cellular injury: Understanding the connection. Epilepsy Behav. 7, 3-11.
17. Fujikawa D. G., Itabashi H. H., Wu A., and Shinmei S. S. (2000a) Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 41, 981-991.
18. Fujikawa D. G., Shinmei S. S., and Cai B. (2000b) Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNAcleavage: implications for programmed cell death mechanisms. Neuroscience 98, 41-53.
19. Gorter J. A., Goncalves Pereira P. M., van Vliet E. A., Aronica E., Lopes da Silva F. H., and Lucassen P. J. (2003) Neuronal cell death in a rat model for mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures. Epilepsia 44, 647-658.
20. Grutter M. G. (2000) Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol. 10, 649-655.
21. Hellier J. L., Patrylo P. R., Buckmaster P. S., and Dudek F. E. (1998) Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res. 31, 73-84.
22. Henshall D. C., Chen J., and Simon R. P. (2000a) Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizures. J. Neurochem. 74, 1215-1223.
23. Henshall D. C., Clark R. S., Adelson P. D., Chen M., Watkins S. C., and Simon R. P. (2000b) Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 55, 250-257.
24. Henshall D. C., Skradski S. L., Bonislawski D. P., Lan J. Q., and Simon R. P. (2001) Caspase-2 activation is redundant during seizure-induced neuronal death. J. Neurochem. 77, 886-895.
25. Hermel E., Gafni J., Propp S. S., et al. (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ. 11, 424-438.
26. Kalviainen R., Salmenpera T., Partanen K., Vainio P., Riekkinen P., and Pitkanen A. (1998) Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 50, 1377-1382.
27. Kitamura Y., Shimohama S., Kamoshima W., et al. (1998) Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res. 780, 260-269.
28. Kondratyev A., Selby D., and Gale K. (2002) Status epilepticus leads to the degradation of the endogenous inhibitor of caspase-activated DNase in rats. Neurosci. Lett. 319, 145-148.
29. Kumar S., Kinoshita M., Noda M., Copeland N. G., and Jenkins N. A. (1994) Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev. 8, 1613-1626.
30. Lewis D. A., Campbell M. J., and Morrison J. H. (1986) An immunohistochemical characterization of somatostatin-28 and somatostatin-281-12 in monkey prefrontal cortex. J. Comp. Neurol. 248, 1-18.
31. Loscher W. (1997) Animal models of intractable epilepsy. Prog. Neurobiol. 53, 239-258.
32. Love S., Barber R., Srinivasan A., and Wilcock G. K. (2000) Activation of caspase-3 in permanent and transient brain ischaemia in man. Neuroreport 11, 2495-2499.
33. Mancini M., Machamer C. E., Roy S., et al. (2000) Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J. Cell Biol. 149, 603-612.
34. Mathern G. W., Babb T. L., Vickrey B. G., Melendez M., and Pretorius J. K. (1995) The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 118, 105-118.
35. Mikkonen M., Soininen H., and Pitkanen A. (1997) Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex. J. Comp. Neurol. 388, 64-88.
36. Mikkonen M., Soininen H., Kalvianen R., et al. (1998) Remodeling of neuronal circuitries in human temporal lobe epilepsy: increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex. Ann. Neurol. 44, 923-934.
37. Nagy Z. and Esiri M. M. (1998) Neuronal cyclin expression in the hippocampus in temporal lobe epilepsy. Exp. Neurol. 150, 240-247.
38. Nairismagi J., Grohn O. H., Kettunen M. I., Nissinen J., Kauppinen R. A., and Pitkanen A. (2004) Progression of brain damage after status epilepticus and its association with epileptogenesis: a quantitative MRI study in a rat model of temporal lobe epilepsy. Epilepsia 45, 1024-1034.
39. Narkilahti S. and Pitkanen A. (2005) Caspase 6 expression in the rat hippocampus during epileptogenesis and epilepsy. Neuroscience 131, 887-897.
40. Narkilahti S., Nissinen J., and Pitkanen A. (2003a) Administration of caspase 3 inhibitor during and after status epilepticus in rat: effect on neuronal damage and epileptogenesis. Neuropharmacology 44, 1068-1088.
41. Narkilahti S., Pirttila T. J., Lukasiuk K., Tuunanen J., and Pitkanen A. (2003b) Expression and activation of caspase 3 following status epilepticus in the rat. Eur. J. Neurosci. 18, 1486-1496.
42. Nicholson D. W. and Thornberry N. A. (1997) Caspases: killer proteases. Trends Biochem. Sci. 22, 299-306.
43. Nissinen J., Large C. H., Stratton S. C., and Pitkanen A. (2004) Effect of lamotrigine treatment on epileptogenesis: an experimental study in rat. Epilepsy Res. 58, 119-132.
44. Olney J. W., Collins R. C., and Sloviter R. S. (1986) Excitotoxic mechanisms of epileptic brain damage. Adv. Neurol. 44, 857-877.
45. Olney J. W., Rhee V., and Ho O. L. (1974) Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res. 77, 507-512.
46. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
47. Pitkanen A. and Sutula T. (2002) Is epilepsy a progressive disease? Prospects for new therapeutic approaches in temporal lobe epilepsy. Lancet Neurol. 173-181.
48. Pitkanen A., Nissinen J., Nairismagi J., et al. (2002) Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog. Brain Res. 135, 67-83.
49. Puig B. and Ferrer I. (2001) Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease. Acta. Neuropathol. (Berl.) 102, 207-215.
50. Salmenpera T., Kalviainen R., Partanen K., and Pitkanen A. (2001) Hippocampal and amygdaloid damage in partial epilepsy: a cross-sectional MRI study of 241 patients. Epilepsy Res. 46, 69-82.
51. Shimohama S., Tanino H., and Fujimoto S. (1999) Changes in caspase expression in Alzheimer's disease: comparison with development and aging. Biochem. Biophys. Res. Commun. 256, 381-384.
52. Siegel S. and Castellan N. (1988) Nonparametric statistics for the behavioral sciences. McGraw-Hill Book Company, New York, 213-214.
53. Schindler C. K., Pearson E. G., Bonner H. P., et al. (2006) Caspase-3 cleavage and nuclear localization of caspase-activated DNase in human temporal lobe epilepsy. J. Cereb. Blood Flow. Metab. 26, 583-589.
54. Sommer W. (1880) Erkrankung des Ammonshorns als aetiologisches moment der epilepsie. Arch. Psychiatr. Nervenkr. 10, 631-675.
55. Sperk G. (1994) Kainic acid seizures in the rat. Prog. Neurobiol. 42, 1-32.
56. Talanian R. V., Quinlan C., Trautz S., et al. (1997) Substrate specificities of caspase family proteases. J. Biol. Chem. 272, 9677-9682.
57. Teitelbaum J., Zatorre R. J., Carpenter S., Gendron D., and Cashman N. R. (1990) Neurological sequelae of domoic acid intoxication. Can. Dis. Wkly. Rep. 16(Suppl. 1E), 9-12.
58. Troy C. M. and Shelanski M. L. (2003) Caspase-2 redux. Cell Death Differ. 10, 101-107.
59. Troy C. M., Stefanis L., Greene L. A., and Shelanski M. L. (1997) Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD) downregulation, in sympathetic neurons and PC12 cells. J. Neurosci. 17, 1911-1918.
60. Troy C. M., Rabacchi S. A., Friedman W. J., Frappier T. F., Brown K., and Shelanski M. L. (2000) Caspase-2 mediates neuronal cell death induced by beta-amyloid. J. Neurosci. 20, 1386-1392.
61. Tuunanen J., Lukasiuk K., Halonen T., and Pitkanen A. (1999) Status epilepticus-induced neuronal damage in the rat amygdaloid complex: distribution, time-course and mechanisms. Neuroscience 94, 473-495.
62. Wang L., Miura M., Bergeron L., Zhu H., and Yuan J. (1994) Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78, 739-750.
63. Wasterlain C. G. and Shirasaka Y. (1994) Seizures, brain damage and brain development. Brain Dev. 16, 279-295.
64. Watson C., Nielsen S. L., Cobb C., Burgerman R., and Williamson B. (1996) Medial temporal lobe heterotopia as a cause of increased hippocampal and amygdaloid MRI volumes. J. Neuroimaging 6, 231-234.
65. Yamamoto A., Murphy N., Schindler C. K., et al. (2006) Endoplasmic reticulum stress and apoptosis signaling in human temporal lobe epilepsy. J. Neuropathol. Exp. Neurol. 65, 217-225.